CONMED Corp — Director's Dealing 2020

Feb 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-01-31

Reporting Person: Hartman Curt R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-31	Common Stock	M	104000	—	Acquired	150704	Direct
2020-01-31	Common Stock	F	48903	$101.68	Disposed	101801	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-31	PSUs (Performance Stock Units)	$0	A	104000	Acquired		Common Stock (104000)	Direct
2020-01-31	PSUs (Performance Stock Units)	$0	M	104000	Disposed		Common Stock (104000)	Direct

Footnotes

F1: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes.